Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

By sjmartinez • October 19, 2023

Jagannathan P, Chew KW, Giganti MJ, Hughes MD, Moser C, Main MJ, Monk PD, Javan AC, Li JZ, Fletcher CV, McCarthy C, Wohl DA, Daar ES, Eron JJ, Currier JS, Singh U, Smith DM, Fischer W; ACTIV-2/A5401 Study Team. Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial. EClinicalMedicine. 2023 Oct 6;65:102250. doi: 10.1016/j.eclinm.2023.102250. PMID: 37855026; PMCID: PMC10579289.

Tags: ACTIV-2, covid-19, Infectious Diseases, Inhaled interferon, Publications, Randomized clinical trial, SARS-CoV-2

The Use of Next-Generation Sequencing to Assist in the Diagnosis of Atypical Vasculitis

Chetrit DA, Aung T, Cheng QJ, King J. The Use of Next-Generation Sequencing to Assist in the Diagnosis of Atypical Vasculitis. Cureus. 2024 Nov 7;16(11):e73247.[...]

Creating a plasma coordination center to support COVID-19 outpatient trials across a national network of hospital blood banks

Yarava A, Marshall C, Reichert DE, Ye A, Khanal P, Robbins SH, Sachais BS, Oh D, Metcalf RA, Conry-Cantilena K, King K, Reyes M, Adamski[...]

When Can a MRSA Nares Swab Guide Antibiotic Stewardship?: What the Nose Knows

Saito AK, Goetz MB, Wu S. When Can a MRSA Nares Swab Guide Antibiotic Stewardship?: What the Nose Knows. JAMA Intern Med. 2024 Dec 9.[...]